Q: Man--Best Q for Rev & EBITDA.But missed EPS expectations 7 of 9 last Qs.Does this indicate a management issue? Is it time for me(p/p $17.28,a 34% loss) to move on?If so.please suggest a replacement(does not have to be in same sector).Initial big pop($12.29H up 0.89),then disappeared to only 0.02 gain for the day.Maybe partially due to u comment this morning.Txs for u usual great services & views
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: This seems to be a reasonably good way to play the major healthcare industry. I am not sure how the covered call aspect of this ETF would play in a rising market, i.e. is it the same as the tech industry, where a covered call aspect would act as a drag on the performance. Your thoughts please.
Thanks, David
Thanks, David
Q: Is it time to get rid of PFE. I've had this for years and done well but it's been on a downward trend for a while now. What was once a 45% gain has dwindled to 13%. This is starting to remind me of GE where you hang on hoping for a turn around and nothing but bad news keeps happening. Thinking of replacing it with CVS. Your opinion is greatly appreciated.
thanks
thanks
Q: CPH just released Q results, do you see things turning around? They have more cash and less debt than last quarter and they continue to make a profit - please evaluate these metrics. Finally, would you comment on the initiatives outlined in the strategic update?
Q: Is there any positives in there latest Quarter???
Q: The worst kept secret is that GUD wants to buy Paladin Labs back from ENDP. As ENDP continues to get crushed by its debt and seemingly more desperate by the day, I would assume that this puts GUD is a better position with each passing moment.
If this is the case, shouldn’t that make GUD more valuable?
If this is the case, shouldn’t that make GUD more valuable?
Q: I recently started a small position in guardant, in the past week or so, share price has dropped, should I increase my position,? Also, do you really like company for longer term growth, current weighting in my portfolio is 1%.
Q: GH price has had a rough week, any particular reason, and do you still like this company on a long term basis for growth, I have a small position and wondering if I should move on, or stick it out.
Q: Hello
Could you comment on CVS and AIG following recent earnings?
Regarding Amazons possible entry into Health market (online pharmacy I believe), has there been any recent news on that?
Thank you
Stephane
Could you comment on CVS and AIG following recent earnings?
Regarding Amazons possible entry into Health market (online pharmacy I believe), has there been any recent news on that?
Thank you
Stephane
Q: GUD is having a good day after Medison came out swinging on Friday. Can you explain why GUD is up today? Is there other news I'm missing?
Q: Medison came out with another negative statement after Knights earnings.
Is this just noise or does Medison have a game plan here.
Would like your thoughts on this.
Thanks John
Is this just noise or does Medison have a game plan here.
Would like your thoughts on this.
Thanks John
Q: Good morning,
VMD is down almost 15 % today. The only news I can see is that they just announced that they will have a listing on Nasdaq. Is it not generally positive news, when a stock is able to have more than one listing? It seems by the reaction that this is viewed negatively.
Thanks,
Jim
VMD is down almost 15 % today. The only news I can see is that they just announced that they will have a listing on Nasdaq. Is it not generally positive news, when a stock is able to have more than one listing? It seems by the reaction that this is viewed negatively.
Thanks,
Jim
Q: Could you discuss the implications of the recent news. Is this change the fundamentals significantly enough to warrant selling today?
Q: Hello 5I Team
What do you make of CTX these days. Positive numbers, buying back shares, patents approved in the us along with some drug sales. Does it look interesting yet? What are the downsides?
Thank You
Clarence
What do you make of CTX these days. Positive numbers, buying back shares, patents approved in the us along with some drug sales. Does it look interesting yet? What are the downsides?
Thank You
Clarence
Q: I have been following GH but did not start a position. Given the strong Q2 results and the momentum in the stock would you initiate a position now or wait for some market volatility?
Q: Good afternoon,
I know US listed stocks are not your focus just looking for an opinion on ZTS quarter numbers that were just reported. It looks good to me, I hold this in a TFSA well diversified. Would you add more to current position? My average cost currently is 94 per share, I am looking for long term capital growth. Thanks
I know US listed stocks are not your focus just looking for an opinion on ZTS quarter numbers that were just reported. It looks good to me, I hold this in a TFSA well diversified. Would you add more to current position? My average cost currently is 94 per share, I am looking for long term capital growth. Thanks
Q: Hi 5i
Would you suggest buying Pfizer today or wait to see what direction the stock price moves. I’m a very long term investor.
Thx
Gerry
Would you suggest buying Pfizer today or wait to see what direction the stock price moves. I’m a very long term investor.
Thx
Gerry
Q: Peter & Co., I am considering a position in NOVO for a 2-3 year hold. May I please have your analysis and recommendation?
With appreciation.
Ed
With appreciation.
Ed
Q: The Globe published this, "Scotiabank analyst Ben Isaacson initiated coverage of MediPharm Labs Corp. with a “sector outperform” rating and $17 target. The average is $7.35."
This seems extreme. Do you know what the analyst's logic was? (or was it a typo somewhere along the way?)
This seems extreme. Do you know what the analyst's logic was? (or was it a typo somewhere along the way?)
Q: I am looking to get some exposure to the health care sector and thought I would look at an ETF as opposed to a single company. I'm considering either XLV or IHI and would like your opinion of these two ETFs, and which you would prefer. I would be adding the ETF as a full position in my RRSP.
Also, if there is another ETF that you prefer over these two, please include that in your response.
thanks for your insight
Paula
Also, if there is another ETF that you prefer over these two, please include that in your response.
thanks for your insight
Paula